Survival with retinoblastoma in the USA: 1975-2004

British Journal of Ophthalmology

Volumn 93, Issue 1, 2009, Pages 24-27

  Broaddus, E ^a,b   Topham, A ^c   Singh, A D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Coalition of National Cancer Cooperative Group Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILATERAL CANCER; BRACHYTHERAPY; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DATA BASE; EXTERNAL BEAM RADIOTHERAPY; EYE; FEMALE; HISTOPATHOLOGY; HOSPITAL; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANK SUM TEST; RETINA; RETINOBLASTOMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; RETINAL NEOPLASMS; RETINOBLASTOMA; SEER PROGRAM; SURVIVAL ANALYSIS; UNITED STATES;

EID: 58349113391     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.143842     Document Type: Article

References (39)

1. Gallia BL, Dunn JM, Chan HS, et al. The genetics of retinoblastoma. Relevance to the patient. Pediatr Clin North Am 1991;38:299-315.
2. McCay CJ, Abramson DH, Ellsworth RM. Metastatic patterns of retinoblastoma. Arch Ophthalmol 1984;102:391-6.
3. Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology 1987;94:371-7.
4. Honavar SG, Singh AD, Shields CL, et al. Post-enucleation prophylactic chemotherapy in high-risk retinoblastoma. Arch Ophthalmol 2002;120:923-31.
5. Jakobiec FA, Tso MOM, Zimmerman LE, et al. Retinoblastoma and intracranial malignancy. Cancer 1977;39:2048-58.
6. Badar JL, Miller RW, Meadows AT, et al. Trilateral retinoblastoma. Lancet 1980;2:582-3.
7. Blach LE, McCormick B, Abramson DH, et al. Trilateral retinoblastoma-incidence and outcome: a decade of experience. Int J Radiat Oncol Biol Phys 1994;29:729-33.
8. Kivela T. Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma [see comments]. J Clin Oncol 1999;17:1829-37.
9. Singh AD, Shields CL, Shields JA. New insights into trilateral retinoblastoma. Cancer 1999;86:3-5.
10. Abramson DH, Ellsworth RM, Kitchin FD, et al. Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced? Ophthalmology 1984,91:1351-5.
11. Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer 1986;53:661-71.
12. Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology 1988;95:1583-7.
13. Moll AC, Imhof SM, Bouter LM, et al. Second primary tumors in patients with retinoblastoma. A review of the literature. Ophthalmic Genet 1997;18:27-34.
14. Wong FL, Boice JD Jr, Abramson DH, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 1997;278:1262-7.
15. Abramson DH, Frank CM. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk [see comments]. Ophthalmology 1998;105:573-9; discussion 9-80.
16. Marcus DM, Brooks SE, Leff G, et al. Trilateral retinoblastoma: insights into histogenesis and management. Sun Ophthalmol 1988:43:59-70.
17. Abramson DH, Ellsworth RM, Grumbach N, et al. Retinoblastoma: correlation between age at diagnosis and survival. J Pediatr Ophthalmol Strabismus 1986;23:174-7.
18. Abramson DH, Ellsworth RM, Grumbach N, et al. Retinoblastoma: survival, age at detection and comparison 1914-1958, 1958-1983. J Pediatr Ophthalmol Strabismus 1985;22:246-50.
19. Young JJL, Smith MA, Roffers SD, et al. In: Ries LAG, Smith MA, Gurney JG, et al.. eds. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995, SEER Program. NIH Pub. No. 99-4649. Bethesda: National Cancer Institute, 1999.
20. Sanders BM, Draper GJ, Kingston JE. Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival. Br J Ophthalmol 1988;72:576-83.
21. Sant M. Capocaccia R, Badioni V, et al. Survival for retinoblastoma in Europe. Eur J Cancer 2001;37:730-5.
22. Senft S, al-Kaff A, Bergqvist G, et al. Retinoblastoma: the Saudi Arabian experience. Ophthalmic Paediatr Genet 1988;9:115-9.
23. Ajaiyeoba IA, Akang EE, Campbell OB, et al. Retinoblastomas in Ibadan: treatment and prognosis. West Afr J Med 1993;12:223-7.
24. Nandakumar A, Anantha N, Appaji L, et al. Descriptive epidemiology of childhood cancers in Bangalore, India. Cancer Causes Control 1996;7:405-10.
25. Pratt CB, Meyer D, Chenaille P, et al. The use of bone marrow aspirations and lumbar punctures at the time of diagnosis of retinoblastoma. J Clin Oncol 1989;7:140-3.
26. Mohney BG, Robertson DM. Ancillary testing for metastasis in patients with newly diagnosed retinoblastoma. Am J Ophthalmol 1994;118:707-11.
27. Imhof SM, Moll AC, Schouten-van Meeteren AY. Stage of presentation and visual outcome of patients screened for familial retinoblastoma: nationwide registration in The Netherlands. Br J Ophthalmol 2006;90:875-8.
28. Ferris FL 3rd, Chew EY. A new era for the treatment of retinoblastoma. Arch Ophthalmol 1996;114:1412.
29. Surveillance and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 17 Regs Limited-Use, November 2006 Sub (1973-2004 varying)- linked to county attributes-total US, 1969-2004 counties. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission. http://www.seer.cancer.gov (accessed 19 Oct 2008). National Cancer Institute, DCPC, Surveillance Program, Cancer Statistics Branch; May 2004, 2007.
30. Ries LAG, Krapcho M, Mariotto A, et al. SEER cancer statistics review, 1975-2004. Bethesda: National Cancer Institute, 2007.
31. Percy C, Holten W, Muir C. International classification for diseases for oncology. 2nd edn. Geneva: World Health Organization, 1990.
32. Kleinbaum DG. Statistics in the health sciences: survival analysis. New York: Springer, 1996.
33. Kleinerman RA, Tucker MA, Tarone RE, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 2005;23:2272-9.
34. Ellsworth RM. The practical mangement of retinoblastoma. Trans Am Ophthalmol Soc 1969;67:462-534.
35. Pendergrass TW, Davis S. Incidence of retinoblastoma in the United States. Arch Ophthalmol 1980;98:1204-10.
36. Tamboli A, Podgor MJ, Horm JW. The incidence of retinoblastoma in the United States: 1974 through 1985. Arch Ophthalmol 1990;108:128-32.
37. Merchant TE. Teletherapy: indications, risks, and new delivery options. In: Singh AD, Damato BE, Pe'er J, et. al. eds. Clinical ophthalmic oncology. Philadelphia: Saunders-Elsevier, 2007.
38. Moll AC, Imhof SM, Schouten-Van Meeteren AY, et al. Second primary tumors in hereditary retinoblastoma: a register-based study, 1945-1997: is there an age effect on radiation-related risk? Ophthalmology 2001;108:1109-14.
39. Inskip PD, Ries AG, Cohen RJ, et al. New malignancies following childhood cancer. In: Curtis RE, Freedman DM, Ron E, et al., eds. New malignancies among cancer survivors: SEER cancer registries, 1973-2000. NIH Publ. No. 05-5302. Bethesda: National Cancer Institute, 2006:465-82.